Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Korro Bio Inc

KRRO
41,02
2,95 (7,75%)
03 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/12/202413:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/12/202413:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/12/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/12/202422:34EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202422:32EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202422:21EDGAR2Form S-3 - Registration statement under Securities Act of..
21/11/202422:01GLOBEKorro to Participate in Upcoming Investor Conferences
21/11/202414:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/11/202414:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/11/202413:35EDGAR2Form 8-K - Current report
21/11/202413:30GLOBEKorro Receives Australian HREC Approval and CTN Clearance to..
14/11/202415:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:00GLOBEKorro to Present at the Jefferies London Healthcare..
13/11/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202422:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:06EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEKorro Reports Third Quarter 2024 Financial Results and..
12/11/202414:28EDGAR2Form 144 - Report of proposed sale of securities
04/11/202413:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/11/202413:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/11/202413:30EDGAR2Form 8-K - Current report
04/11/202413:25GLOBEKorro Announces Regulatory Filing for Initiation of KRRO-110..
19/10/202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202422:22EDGAR2Form 144 - Report of proposed sale of securities
16/10/202419:05EDGAR2Form 144 - Report of proposed sale of securities
30/9/202414:00GLOBEKorro Announces Oral and Poster Presentations at the 20th..
16/9/202414:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/9/202414:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/9/202414:05EDGAR2Form 8-K - Current report
16/9/202414:00GLOBEKorro Bio Announces Collaboration with Novo Nordisk to..
10/9/202414:00GLOBEKorro to Participate in Upcoming Investor Conferences
04/9/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202401:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/8/202423:28EDGAR2Form 144 - Report of proposed sale of securities
29/8/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202401:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/8/202422:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/8/202422:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/8/202422:10EDGAR2Form 8-K - Current report
28/8/202414:00GLOBEKorro Announces Addition of Industry Veteran Katharine..
27/8/202414:00GLOBEKorro to Participate in Upcoming September Investor and..
13/8/202422:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:06EDGAR2Form 8-K - Current report
13/8/202422:01GLOBEKorro Reports Second Quarter 2024 Financial Results and..
01/7/202414:00GLOBEKorro Joins the Russell 2000®, Russell 3000®, and Russell..
Apertura: 38,99 Min: 38,46 Max: 43,34
Chiusura: 38,07

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network